Data supporting the angiotensin II activates MEL18 to deSUMOylate HSF2 for hypertension-related heart failure

  • Chih Yang Huang
  • , Chia Hua Kuo
  • , Pei Ying Pai
  • , Tsung Jung Ho
  • , Yueh Min Lin
  • , Ray Jade Chen
  • , Fuu Jen Tsai
  • , V. Vijaya Padma
  • , Wei Wen Kuo
  • , Chih Yang Huang

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

In association with the published article “Inhibition of HSF2 SUMOylation via MEL18 upregulates IGF-IIR and leads to hypertension-induced cardiac hypertrophy” (Huang et al., 2017) [1], this data article contains information about deSUMOylation of HSF2 on lysine 82 on angiotensin II (ANG II) -induced cardiac hypertrophy, which is mediated by MEL18. Isolated adult human whole heart tissue showed MEL18-mediated HSF2-IGF-IIR pathway is upregulated in hypertension human heart, compared to health human heart.

Original languageEnglish
Pages (from-to)521-526
Number of pages6
JournalData in Brief
Volume16
DOIs
Publication statusPublished - Feb 1 2018

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'Data supporting the angiotensin II activates MEL18 to deSUMOylate HSF2 for hypertension-related heart failure'. Together they form a unique fingerprint.

Cite this